Grant: Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
University of Guelph
$90,837.00
The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity
EF 2008-09
Résumé
Adipokines are hormone-like compounds released from fat cells, and are involved in numerous physiological processes, including reproductive function, energy expenditure, and inflammation. Many of these compounds are also known to modulate the response of tissues such as muscle and liver to insulin. Obesity is typically characterized by insulin resistance, a condition in which the ability of insulin to promote the uptake of blood sugar into muscle, as well as to control the release of sugar from the liver into the blood, is impaired. Ultimately, this leads to increased blood sugar concentration. Adipokines represent a potential link between the accumulated fat mass in obesity, and the frequently associated loss of insulin sensitivity. Two of the more extensively researched adipokines include leptin and adiponectin, which actually improve insulin sensitivity. Interestingly, the sensitivity of liver and muscle to leptin and adiponectin is impaired in obesity, suggesting that this may be an important factor in the development of insulin resistance. The studies described in this grant will examine the mechanisms by which leptin and adiponectin improve muscle insulin sensitivity, whether improved sensitivity to these adipokines can in turn alter insulin sensitivity, and how lifestyle factors such as diet and exercise affect the sensitivity of muscle to adipokines.
Programme
Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
183246
Name
Dyck David J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Metabolism
Projecttitle
The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$90,837
Cihrequipment2
$0
Programname2
Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
Keyworddelim
Adipokines; Aerobic Training; Fatty Acid Metabolism; Incubations; Obesity / Type Ii Diabetes; Skeletal Muscle
Abstract
Adipokines are hormone-like compounds released from fat cells, and are involved in numerous physiological processes, including reproductive function, energy expenditure, and inflammation. Many of these compounds are also known to modulate the response of tissues such as muscle and liver to insulin. Obesity is typically characterized by insulin resistance, a condition in which the ability of insulin to promote the uptake of blood sugar into muscle, as well as to control the release of sugar from the liver into the blood, is impaired. Ultimately, this leads to increased blood sugar concentration. Adipokines represent a potential link between the accumulated fat mass in obesity, and the frequently associated loss of insulin sensitivity. Two of the more extensively researched adipokines include leptin and adiponectin, which actually improve insulin sensitivity. Interestingly, the sensitivity of liver and muscle to leptin and adiponectin is impaired in obesity, suggesting that this may be an important factor in the development of insulin resistance. The studies described in this grant will examine the mechanisms by which leptin and adiponectin improve muscle insulin sensitivity, whether improved sensitivity to these adipokines can in turn alter insulin sensitivity, and how lifestyle factors such as diet and exercise affect the sensitivity of muscle to adipokines.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dyck, David J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $90,837~ $0~